Liraglutide
Awaiting source reviewLiraglutide is a catalogue entry whose compound-specific reference review has not yet been completed.
- Category
- GLP-1
- Recorded packages
- 1 offers · 1 vendors
- Current in-stock offers
- 1
- Latest price source
- Sep 16, 2026
Search 177 catalogue identities by name or alias. Find recorded vendor packages, markets and cited reference notes in one place.
15 entries have a reviewed selection of primary sources. Other entries are marked as awaiting review. A source review covers the stated claims; it does not certify a vendor, a batch, clinical efficacy or suitability for human use.
Categories such as “Healing” and “Weight Loss” are catalogue navigation labels, not evidence of an effect or an approved use. Similar names can identify different compounds; source notes flag reviewed distinctions.
Liraglutide is a catalogue entry whose compound-specific reference review has not yet been completed.
Livagen is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: cathelicidin
LL-37 is a catalogue entry whose compound-specific reference review has not yet been completed.
Matrixyl is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: glp-1 glucagon dual
Mazdutide is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: mt1 · mt-1 · afamelanotide
Melanotan-1 is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: mt2 · mt-2
Melanotan-2 is a catalogue entry whose compound-specific reference review has not yet been completed.
Melanotan-2 Spray is a catalogue entry whose compound-specific reference review has not yet been completed.
Methylene Blue Solution is a catalogue entry whose compound-specific reference review has not yet been completed.
MGF is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: ibutamoren
MK-677 is a catalogue entry whose compound-specific reference review has not yet been completed.
MK-677 Solution is a catalogue entry whose compound-specific reference review has not yet been completed.
MK-777 (Acetamoren) is a catalogue entry whose compound-specific reference review has not yet been completed.
MOTS-c is a catalogue entry whose compound-specific reference review has not yet been completed.
N-Acetyl Epitalon Amidate is a catalogue entry whose compound-specific reference review has not yet been completed.
N-Acetyl Selank is a catalogue entry whose compound-specific reference review has not yet been completed.
N-Acetyl Semax is a catalogue entry whose compound-specific reference review has not yet been completed.
N-Acetyl Semax Amidate is a catalogue entry whose compound-specific reference review has not yet been completed.
NAD+ is nicotinamide adenine dinucleotide, a nucleotide coenzyme rather than a peptide. A small human pilot examined plasma and urine metabolites during an intravenous infusion.
NAD+ Oral Spray is a catalogue entry whose compound-specific reference review has not yet been completed.
NAD+ Spray is a catalogue entry whose compound-specific reference review has not yet been completed.
Nefiracetam Powder is a catalogue entry whose compound-specific reference review has not yet been completed.
Nonapeptide-1 is a catalogue entry whose compound-specific reference review has not yet been completed.
Noopept Powder is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: mk-2866
Ostarine is a catalogue entry whose compound-specific reference review has not yet been completed.
Ovagen is a catalogue entry whose compound-specific reference review has not yet been completed.
Oxytocin is a catalogue entry whose compound-specific reference review has not yet been completed.
Oxytocin Nasal Spray is a catalogue entry whose compound-specific reference review has not yet been completed.
Oxytocin Oral Spray is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: p-21
P21 is a catalogue entry whose compound-specific reference review has not yet been completed.
Pal-AHK is a catalogue entry whose compound-specific reference review has not yet been completed.
Pal-GHK is a catalogue entry whose compound-specific reference review has not yet been completed.
Pancragen is a catalogue entry whose compound-specific reference review has not yet been completed.
PE-22-28 is a catalogue entry whose compound-specific reference review has not yet been completed.
PEG MGF is a catalogue entry whose compound-specific reference review has not yet been completed.
Pentapeptide-18 (Leuphasyl) is a catalogue entry whose compound-specific reference review has not yet been completed.
Phenibut FAA Powder is a catalogue entry whose compound-specific reference review has not yet been completed.
Phenibut HCl Powder is a catalogue entry whose compound-specific reference review has not yet been completed.
Pinealon is a catalogue entry whose compound-specific reference review has not yet been completed.
PNC-27 is a catalogue entry whose compound-specific reference review has not yet been completed.